S48168 regulatory update
FDA granted rare pediatric disease and Orphan Drug designation to ARM210 from Armgo to treat Duchenne muscular dystrophy (DMD). ARM210 is in Phase I testing for DMD. The product is an oral Rycal, a small...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
